EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Role of TRAF6 in Cancer: From Molecular Mechanisms to Therapeutic Strategies

Shuai Xiao iD, Dandan Song, Yeping Yu, Lingli Tian, Xiaozhen Xu, Wenying Qin, Rui Zhang, Hao Lyu, Dong Guo, Qi Zhang iD, Xing-Zhen Chen, Jingfeng Tang iD und 1 weitere

Cells · 2026

DOI: 10.3390/cells15090818 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, 2026. Verfasst von Shuai Xiao und 12 weiteren Autor:innen. Beteiligte Einrichtung: National "111" Center for Cellular Regulation and Molecular Pharmaceutics, Hubei University of Technology, Wuhan 430068, China. Hauptthemen laut MEDLINE: TNF Receptor-Associated Factor 6, Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 208 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Key R&D Program of China, Innovation Group Project of Hubei Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tumor necrosis factor receptor-associated factor 6 (TRAF6) is an E3 ubiquitin ligase that plays a crucial role in inflammation, immune responses, and tumor development. It was reported that TRAF6 primarily catalyzes K63-linked polyubiquitination to stabilize substrate proteins, thereby facilitating the malignant phenotype of tumors. Beyond its cytoplasmic roles, TRAF6 undergoes nuclear translocation in response to specific stimuli, where it interacts with chromatin modifiers. TRAF6 acts as a central mediator in key signaling pathways downstream of the Toll-like receptor, interleukin-1 receptor, and tumor necrosis factor receptor superfamilies, including NF-κB activation. TRAF6 exerts diverse oncogenic functions, including promoting cell proliferation, migration, metastasis, immune evasion, and therapy resistance. This involves modulating cellular pathways such as NF-κB and MAPK signaling, which contribute to malignant progression. Aberrant TRAF6 activation contributes to the pathogenesis of multiple malignancies, including colorectal cancer, melanoma, hepatocellular carcinoma, and acute myeloid leukemia, making it a promising therapeutic target for cancer treatment. This review summarizes the structural features, substrate diversity, and multifaceted roles of TRAF6 in cancer, as well as the development of TRAF6-targeting drugs and strategies. We hope this review can provide a comprehensive perspective on TRAF6-targeted therapeutic strategies for cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TNF Receptor-Associated Factor 6NeoplasmsHumansAnimalsSignal TransductionUbiquitinationNF-kappa BIntracellular Signaling Peptides and Proteins

Stichwörter der Autor:innen

NF-κB signalingTRAF6therapeutic targettumorubiquitination

Substanzen

TNF Receptor-Associated Factor 6NF-kappa BTifab protein, humanIntracellular Signaling Peptides and Proteins

Autor:innen und Institutionen

  • National "111" Center for Cellular Regulation and Molecular Pharmaceutics, Hubei University of Technology, Wuhan 430068, China.
  • Henan Key Laboratory of Tea Plant Biology, College of Tea and Food Science, Xinyang Normal University, Xinyang 464000, China.
  • Protein Disease Research Group, Department of Physiology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB T6G 2R3, Canada.

ORCID-Profile: Shuai Xiao, Qi Zhang, Jingfeng Tang, Cefan Zhou

Förderung

  • National Natural Science Foundation of China
  • National Key R&D Program of China
  • Innovation Group Project of Hubei Province
  • Key Cultivation Project of Hubei Province for Science and Technology
  • National Natural Science Foundation of Hubei

Zitieren

APA

Xiao, S., Song, D., Yu, Y., Tian, L., Xu, X., Qin, W., Zhang, R., Lyu, H., Guo, D., Zhang, Q., Chen, X. Z., Tang, J., & Zhou, C. (2026). The Role of TRAF6 in Cancer: From Molecular Mechanisms to Therapeutic Strategies. Cells. https://doi.org/10.3390/cells15090818

Vancouver

Xiao S, Song D, Yu Y, Tian L, Xu X, Qin W, et al. The Role of TRAF6 in Cancer: From Molecular Mechanisms to Therapeutic Strategies. Cells. 2026. doi:10.3390/cells15090818

BibTeX
@article{Xiao2026,
  author = {Xiao, Shuai and Song, Dandan and Yu, Yeping and Tian, Lingli and Xu, Xiaozhen and Qin, Wenying and Zhang, Rui and Lyu, Hao and Guo, Dong and Zhang, Qi and Chen, Xing-Zhen and Tang, Jingfeng and Zhou, Cefan},
  title = {The Role of TRAF6 in Cancer: From Molecular Mechanisms to Therapeutic Strategies},
  journal = {Cells},
  year = {2026},
  doi = {10.3390/cells15090818}
}
Kostenlos starten →